VERAMORPH LLC — National Science Foundation SBIR Phase I: BM

VERAMORPH LLC — SBIR Phase I award from National Science Foundation.

Amount
$225,000
Agency
National Science Foundation
Program / Phase
SBIR · Phase I
Topic
BM
NAICS
Place of performance
DE
Period
2020-08-01 → 2021-07-31

Description

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve the efficacy of drug products through a novel tablet. Current formulation technologies have limited compatibility with the estimated 6